Agilent Technologies Inc. (NYSE: A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for...
Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading...
Makers of crucial lab equipment and materials for the healthcare industry play a vital, though often overlooked, role for some higher-risk companies.
Test enables identification of patients whose tumors express PD-L1 for potential treatment with KEYTRUDA® (pembrolizumab) 1, 2
Q4 Earnings Outperformers: Agilent (NYSE:A) And The Rest Of The Research Tools & Consumables Stocks
Expanded PD‑L1 indication and end‑to‑end digital pathology workflows support modern pathology practice
/Waters%20Corp_%20phone%20logo%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
Waters Corporation stock has underperformed the Dow over the past year, but analysts remain moderately bullish about its prospects.